Author:
Huntjens Dymphy R.,Liefaard Lia C.,Nandy Partha,Drenth Henk-Jan,Vermeulen An
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference21 articles.
1. Tzschentke TM, Christoph T, Kögel B, Schiene K, Hennies HH, Englberger W, Haurand M, Jahnel U, Cremers TI, Friderichs E, De Vry J. (−)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther. 2007;323(1):265–76.
2. Palexia® (tapentadol) oral film-coated tablets [summary of product characteristics]. Aachen: Gruenenthal GmbH; 2011.
3. Palexia® SR (tapentadol) prolonged release oral tablets [summary of product characteristics]. Aachen: Gruenenthal GmbH; 2011.
4. Nucynta. Nucynta® ER (tapentadol) extended release oral tablets C-II [prescribing information]. Raritan: Janssen Pharmaceuticals, Inc; 2011.
5. Terlinden R, Kogel BY, Englberger W, Tzschentke TM. In vitro and in vivo characterization of tapentadol metabolites. Methods Find Exp Clin Pharmacol. 2010;32(1):31–8.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献